Current Research Studies

A Phase 2, Open-Label Extension Study to Assess the Safety and Efficacy of GLM101 Administered Intravenously to Participants with PMM2-CDG

GLM101-007

  • Condition(s): Other
  • Phase: II
  • Clinicaltrials.gov ID: NCT06657859

What is the goal of the study?

This is an open-label extension study to assess the long-term safety of continued dosing of GLM101 in participants with PMM2-CDG who have previously received GLM101.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: